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Abstract. Chronic pancreatitis results when pancreatic structure or func-
tion is irreversibly damaged by repeated or ongoing inflammation, regard-
less of the underlying etiology. Most patients present with medically intrac-
table pain and radiological evidence of diffuse gland involvement. Surgical
therapy is directed mainly toward palliation of symptoms, and cure is un-
usual except when the inflammatory process is limited to a specific segment
of the pancreas. Surgical strategy should be individualized on the basis of
alterations in pancreatic morphology and duct anatomy. In properly se-
lected patients, duct drainage procedures effectively relieve pain and pre-
serve pancreatic function with low perioperative morbidity and mortality.
Extensive distal pancreatectomy is effective in relieving pain, but it can be
technically challenging and in general should be limited to patients with
small-duct disease because of severe metabolic consequences. Intraportal
islet cell autotransplantation or segmental pancreatic autotransplantation
may ameliorate the long-term effects of insulin-dependent diabetes, but it
will have limited applicability until methods for optimizing and purifying
islets are developed and the optimal route and site of islet cell implantation
have been identified.
Chronic pancreatitis is prevalent throughout the world, but the eti-
ologies and clinical course vary in different regions. Although the
pathophysiology remains unclear, the clinical manifestations of
pain and malabsorption occur with predictable regularity. The in-
flammatory component of the disease is incurable, and conven-
tional treatment strategies are directed toward palliation of symp-
toms and management of complications. Medical treatment is
generally effective, and fewer than one-third of patients require
surgery during the course of their disease [1].
Pain is, without question, the most common and troublesome
presenting symptom in patients with chronic pancreatitis. The
pathogenesis is complex, multifactorial, and poorly understood.
The two most widely accepted and well-studied mechanisms of
chronic pain include “pancreatic duct-parenchymal hypertension”
and “perineural inflammation.” Several authors have demon-
strated elevated pancreatic tissue pressure in patients with painful
pancreatitis and noted good correlation between relief of pain and
normalization of tissue pressure after duct decompression [2, 3].
The concept of pancreatitis-associated neuritis was suggested by
Bockman et al., and is based on histologic evidence of dispropor-
tionate round cell infiltration of pancreatic nerve plexuses [4]. Pre-
sumably, cytotoxic enzymes released by eosinophils and other
round cells damage the normal perineural barrier and permit the
influx of inflammatory mediators and pancreatic enzymes, causing
pain.
Indications for Surgery
The course of chronic pancreatitis is erratic, but in severe cases it
can progress to intractable pain, inanition, and chemical depen-
dency with narcotic habituation, loss of gainful employment, and
the need for repeated hospitalizations. Intractable pain continues
to be the main indication for surgical intervention. Although elimi-
nation of the underlying cause (e.g., alcohol) may alter the clinical
course of the disease, morphological changes such as duct obstruc-
tion, calculus formation, and fibrosis ultimately perpetuate paren-
chyma damage. The restrictive effects of ongoing inflammation
and fibrosis result in a situation that is analogous to “compartment
syndromes” observed in other areas of the body.
The purported goal of medical, endoscopic, and surgical ap-
proaches is reduction of ductal and parenchymal hypertension.
Surgical intervention is limited to managing complications of the
disease, but timing of surgery and selection of a specific surgical
approach that is both safe and effective remain controversial. No
single surgical procedure is uniformly appropriate for all patients
with painful pancreatitis. Because there is no clear-cut association
between the pain of chronic pancreatitis and the results of imaging
and/or function studies, therapeutic recommendations should con-
tinue to be based primarily on clinical assessment. Operative strat-
egy should be individualized on the basis of alterations in pancre-
atic morphology and duct anatomy. The severity and chronicity of
pain, as well as the degree of narcotic analgesic and other chemical
dependencies, should be assessed. Nutritional and immunologic
parameters should be measured preoperatively, and provision of
enteral or parenteral supplements should be considered in any pa-
tient with extreme weight loss and/or malnutrition.
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creatic endocrine and exocrine insufficiency, respectively. The
combination of these findings with radiological evidence of glan-
dular calcification in a patient with painful pancreatitis generally
connotes irreversible disease that is unlikely to respond to contin-
ued medical management. With continued refinement of diagnos-
tic imaging studies, the importance of pancreatic function studies
has diminished. Although somewhat cumbersome and technology-
dependent, the secretin-cholecystokinin stimulation test with duo-
denal intubation remains the “gold standard” for diagnosing
chronic pancreatitis [5]. Additional studies are available, but they
tend to be expensive and are relatively insensitive in early stages of
chronic pancreatitis.
The success of surgical intervention ultimately is dependent on
tailoring a specific procedure to each individual patient’s needs.
This in turn is determined by the patient’s pancreatic morphology
and ductal anatomy. Plain radiographs of the abdomen help to es-
tablish the diagnosis of chronic pancreatitis, but they are rarely
helpful in planning operative intervention. Computed tomography
(CT) and endoscopic retrograde cholangiopancreatography
(ERCP) remain the mainstays of diagnosis. In particular, ERCP is
useful in identifying abnormalities that might alter the surgical ap-
proach, and it provides potential access for nonoperative treatment
of strictures and stones. Despite initial enthusiasm for endoscopic
treatment of strictures and stones, critical analysis suggests that it is
currently experimental and should be limited to centers participat-
ing in comparative, prospective trials [6].
Computed tomography may be useful in demonstrating unsus-
pected complications (e.g., pseudocyst or splenic vein thrombosis)
that might alter surgical strategy. Visceral angiography is rarely in-
dicated because sophisticated helical or spiral CT scans can reliably
demonstrate relevant peripancreatic vascular anatomy. However,
angiography may be useful in selected patients with suspected or
proven pancreatitis-associated visceral pseudoaneurysms in whom
operative intervention is contemplated.
Distal pancreatectomy is indicated for chronic pancreatitis pa-
tients with intractable pain in whom most of the disease is limited to
the distal pancreas and for patients with “small-duct” disease in
whom a duct drainage procedure is not likely to be successful. Duct
drainage is clearly preferred in patients with “large-duct” pancre-
atitis characterized by marked dilatation (> 7–8 mm) of the main
pancreatic duct, because it can be accomplished with low morbidity
and mortality, is technically less challenging than formal pancreatic
resection, and preserves islet cell mass, thereby reducing the like-
lihood of insulin-dependent diabetes. Reoperation rates approach-
ing 20% after initial duct decompression indicate inadequate
drainage or disease progression. Several technical maneuvers are
critical to insure the success of duct decompression. First, a long
segment (8–10 cm) of duct must be unroofed. Second, intraductal
concretions obstructing side branches should be carefully removed
to eliminate foci of smoldering pancreatitis. Third, probe patency
of the proximal pancreatic duct should be demonstrated. Fourth,
the intestinal and pancreatic duct mucosa should be carefully ap-
posed to insure long-term anastomotic patency.
In addition to relieving pain in up to 80% of patients, drainage
operations for large-duct pancreatitis may also help to preserve
pancreatic endocrine and exocrine function. Several authors have
observed improvements in diabetes with stabilization of insulin re-
quirements as well as preservation of exocrine function after a
modified Puestow procedure [7, 8]. These data have led to liberal-
ization of the indications for surgical duct decompression, espe-
cially in patients with preserved pancreatic function and only mild
to moderate pain. The reported operative risks for duct decom-
pression and pancreatic resection are generally comparable. How-
ever, extensive distal pancreatic resection can be a formidable un-
dertaking and is associated with a high incidence of metabolic
complications related to pancreatic endocrine and exocrine insuf-
ficiency. Some authors question the efficacy of distal resection for
pain management, even with radiological evidence of a stricture or
occlusion of the pancreatic duct [9]. However, most surgeons be-
lieve that limited distal pancreatectomy is indicated in selected pa-
tients with chronic inflammation or a pseudocyst confined to the
tail of the gland. Other indications for distal resection include sus-
pected malignancy and left-sided, or sinistral, portal hypertension
resulting from splenic vein thrombosis.
Preservation of the spleen during distal pancreatectomy is desir-
able because of its immunological role in opsonization of encapsu-
lated bacteria, but it is not always technically feasible because of
inflammation and fibrosis that obscure normal anatomical planes
in the splenic hilum. The procedure can either begin distally with
mobilization and elevation of the spleen and pancreatic tail or
proximally with division of the neck of the pancreas. Warshaw de-
scribed a technique in which the main splenic artery and vein are
deliberately divided, maintaining splenic viability through the short
gastric vessels [10]. Although attempted spleen preservation in pa-
tients with chronic pancreatitis undergoing distal resection is
worthwhile, a word of caution is warranted. Because of perturba-
tions in anatomy, successful splenic preservation can be achieved in
less than one-third of these patients. Furthermore, division of the
main splenic vessels can infrequently lead to left-sided portal hy-
pertension and variceal bleeding that might later require splenec-
tomy.
The results of limited distal pancreatectomy are difficult to in-
terpret because the technique(s) of resection and the indications
for resection are highly variable. Sawyer and Frey showed that strict
patient selection based on radiological evidence of disease limited
to the body and tail of the pancreas, as well as clinical inspection of
the gland at the time of operation, was critical for determining out-
come [11]. In their series of 17 patients with small-duct disease, 9 of
10 properly selected patients had a good result, whereas none of the
7 patients with more diffuse disease had a good result. Of these 7
patients, 5 required reoperation within 12 months of their initial
surgery. In a more recent study, Rattner et al. achieved fair to good
results in 14 of 20 patients (70%) with small-duct disease, and they
observed that patients with unequivocal evidence of disease limited
to the tail of the pancreas were most likely to have a good result [9].
Extensive or near-total distal pancreatectomy has generally been
reserved for patients with small-duct disease or recurrent pain after
a duct drainage procedure or limited pancreatic resection. This
procedure removes 80% to 95% of the distal pancreas, leaving in
situ a small rim of gland along the C-loop of the duodenum. This
operative technique is well illustrated in Cameron’s Atlas of Surgery
[12]. Briefly, the procedure consists of mobilizing the tail, body, and
neck of the pancreas away from the portal and superior mesenteric
veins, and exposing the uncinate process by dissecting it from be-
neath the superior mesenteric artery and vein. Having fully mobi-
lized the uncinate process from the retroperitoneum, a metal dila-
tor or semi-rigid catheter is placed within the common bile duct to
ascertain its position and course through the substance of the pan-
creatic head. Once the course of the common bile duct has been
established, the pancreas is divided, leaving a 0.5- to 1.0-cm rim of
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tissue to protect the bile duct from injury. Preservation of both pan-
creaticoduodenal arteries is preferable, but one can be ligated
without compromising the viability of the duodenum. Inadvertent
ligation of both pancreaticoduodenal arteries necessitates duode-
nectomy. Once the pancreas has been divided, the pancreatic duct
is identified and ligated. In all cases the pancreatic remnant should
be drained externally.
The results of near-total distal pancreatectomy (NTP) for pain-
ful chronic pancreatitis should lead us to question the efficacy of
this procedure. Keith et al. demonstrated complete freedom from
pain on long-term follow-up in 16 of 32 patients (50%) who under-
went 80% distal resection with only one postoperative death [13].
Fifty percent of patients developed new-onset diabetes, but man-
agement was uncomplicated in those patients who abstained from
alcohol. In a similar study, Eckhauser et al. evaluated 87 patients
who underwent NTP for management of intractable pain resulting
from chronic pancreatitis [14]. Significant improvement or com-
plete pain relief was achieved in 75% of patients, with a perioper-
ative mortality rate of 3.4%. Fourteen percent of patients remained
narcotic dependent. Of the 44 patients who developed insulin-
dependent diabetes after operation, 36 (82%) were new-onset dia-
betics who had no evidence of glucose intolerance prior to opera-
tion. The cumulative survival rate at 10 years was 60%, and contrary
to what we might have predicted, was comparable in patients with
alcoholic and non-alcoholic etiologies.
Intraportal islet cell autotransplantation and segmental pancre-
atic autotransplantation may ameliorate the metabolic complica-
tions of extensive pancreatic resection, but the efficacy of these
strategies remains unproved. Of the 71 cases of intraportal islet cell
autotransplantation reported by Sutherland and Najarian, 33 pa-
tients (46%) remained insulin-independent for an extended time
after surgery [15]. The main obstacles to successful islet cell auto-
transplantation include our inability to preoperatively assess ad-
equacy of islet cell mass, suboptimal techniques for isolating and
purifying islets, and lack of understanding regarding the optimal
site and route of islet cell implantation.
Segmental pancreatic autotransplantation is another potential
treatment option to avoid insulin dependence after extensive pan-
creatic resection, but clinical data are sparse. Fewer than 25 cases
have been reported, with a 20% operative failure rate and a 14%
insulin-independence rate in patients followed for a minimum of 2
years [16]. The major complications of this approach are related to
controlling pancreatic exocrine secretions, ensuring early graft sur-
vival, and optimizing late graft function. Until better solutions are
developed to reduce the incidence of post-transplant fistulas and to
halt whatever changes are responsible for progression deteriora-
tion of graft function over time, these procedures will have limited
applicability in the management of these difficult chronic pancre-
atitis patients.
Summary and Conclusions
The treatment of chronic pancreatitis must be highly individual-
ized, because no uniform approach is applicable to all patients.
Therapeutic decisions should be based on objective information
pertaining to duct anatomy and pancreatic function and should be
tempered by awareness of the metabolic perturbations that accom-
pany extensive pancreatic resection. Patients with large-duct dis-
ease who fail endoscopic therapy should be considered initially for
duct drainage rather than pancreatic resection to relieve pain and
possibly delay irreversible impairment of pancreatic function.
Small-duct disease presents a particularly difficult problem. Lim-
ited distal resection may be warranted in selected patients with fo-
cal disease involving the body and tail of the pancreas. However,
most of these patients will require more extensive resection. The
metabolic consequences of near-total distal pancreatectomy are
significant and may be prohibitive in patients with underlying alco-
holism who are unable or unwilling to remain abstinent following
operation. The endocrine sequelae of NTP can be partially offset
by segmental pancreatic autotransplantation or intraportal islet
cell transplantation, but availability of these techniques is generally
limited to referral centers with established expertise. Interpreta-
tion of data from clinical trials comparing different operative ap-
proaches is difficult because classification criteria have not been
standardized. Improved efforts to classify the severity of chronic
pancreatitis based on evaluation of changes in pancreatic morphol-
ogy and function will become increasingly important in the com-
parison of the results obtained with different therapies.
Résumé. On parle de pancréatite chronique lorsque la structure ou la
fonction pancréatique sont lésées de façon irréversible par une inflammation
répétée ou continue, quelle qu’en soit l’étiologie. La plupart des patients
ont une douleur rebelle et des signes radiologiques intéressant toute la
glande. La thérapeutique chirurgicale a comme but de pallier les
symptômes: la cure est peu fréquente sauf lorsque l’inflammation est
limitée à une seule portion du pancréas. La stratégie chirurgicale doit être
individualisée, basée sur les altérations de la morphologie pancréatique et
sur l’anatomie canalaire. Chez des patients sélectionnés, les procédés de
drainage permettent de bien soulager la douleur et de conserver une
fonction pancréatique avec une morbidité et mortalité périopératoires
acceptables. La pancréatectomie distale étendue, même si elle est efficace
en ce qui concerne le soulagement de la douleur, peut être techniquement
un défi et en général, devrait être indiquée uniquement aux patients dont
les canaux ne sont pas dilatés en raison des conséquences métaboliques
sévères. L’autotransplantation pancréatique segmentaire ou intra portale
des ı̂lots de pancréas peuvent améliorer les résultats à long terme en ce qui
concerne le diabète insulinodépendant, mais pourrait avoir une
applicabilité limitée jusqu’à ce que l’on développe des méthodes pour
optimiser et purifier les ı̂lots ainsi que d’identifier la route et le site idéal de
l’implantation des ı̂lots.
Resumen. A parte de la enfermedad subyacente, la pancreatitis crónica se
origina como consecuencia de las lesiones irreversibles de la morfologı́a o
función del páncreas, secundarios a procesos inflamatorios reiterativos.
La mayorı́a de los pacientes aquejan un dolor incoercible, resistente a todo
tratamiento médico, observándose radiológicamente una afectación difusa
de la glándula. El tratamiento quirúrgico tiene por objeto paliar la
sintomatologı́a ya que no existe cura posible, excepto en aquellos casos en
los que el proceso inflamatorio se limite a un segmento especı́fico de la
glándula. La estrategia quirúrgica ha de individualizarse basándose en las
alteraciones morfológicas del páncreas y de la anatomı́a del Wirsung y
conductos colaterales. En pacientes bien seleccionados, las operaciones
que permiten drenar el Wirsung son eficaces tanto para el tratamiento del
dolor como para preservar la función pancreática, cursando con escasa
morbi-mortalidad postoperatoria. La pancreatectomı́a distal ampliada, es
eficaz para aliviar el dolor, pero puede ser dificultosa desde el punto de
vista técnico; por lo general su indicación queda limitada a pacientes con
Wirsung estrecho pues conlleva graves alteraciones metabólicas. El
autotrasplante de islotes de celulas de Langerhans a través de la vena
porta y de segmentos pancreáticos, mejoran a largo plazo la diabetes
insulinodependiente; para que sean más efectivos se requiere optimizar la
purificación de los islotes e identificar la vı́a y la ubicación idónea de los
mismos.
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